Home - Products - Others - Other Targets - Fructo-oligosaccharide DP13/GF12

Fructo-oligosaccharide DP13/GF12

CAS No. 137405-37-9

Fructo-oligosaccharide DP13/GF12( ——— )

Catalog No. M38927 CAS No. 137405-37-9

Fructo-oligosaccharide DP13 is an Inulin -type fructo-oligosaccharide that can be isolated from Morinda Officinalis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Fructo-oligosaccharide DP13/GF12
  • Note
    Research use only, not for human use.
  • Brief Description
    Fructo-oligosaccharide DP13 is an Inulin -type fructo-oligosaccharide that can be isolated from Morinda Officinalis.
  • Description
    Fructo-oligosaccharide DP13 is an Inulin-type fructo-oligosaccharide that can be isolated from Morinda Officinalis.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    137405-37-9
  • Formula Weight
    2125.84
  • Molecular Formula
    C78H132O66
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chi L, et al. Development and application of bio-sample quantification to evaluate stability and pharmacokinetics of inulin-type fructo-oligosaccharides from Morinda Officinalis. J Pharm Biomed Anal. 2018 Jul 15;156:125-132.?
molnova catalog
related products
  • NTRC 0066-0

    NTRC 0066-0 is an orally available, selective and potent inhibitor of threonine tyrosine kinase (TTK) that inhibits phosphorylation of TTK substrates and induces chromosome missegregation in cell lines and mice for cancer research.

  • Anti-Kentsin

    Anti-Kentsin

  • Cerdulatinib hydroch...

    Cerdulatinib (PRT-062070) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively.